Loading clinical trials...
Loading clinical trials...
The aim of this trial is to assess the effect of Empagliflozin on lipid and glucose metabolism as well as volume homeostasis and renal function in elderly and obese patients with increased risk of dev...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Jacob Moller
Collaborators
NCT05545306 · Obesity, Normal Physiology, and more
NCT07187830 · Chronic Kidney Disease in Type 2 Diabetes, Obesity & Overweight
NCT04453072 · Obesity, Malignant Neoplasm
NCT07565051 · Morbid Obesity Requiring Bariatric Surgery
NCT03999138 · Acute Heart Failure, Pulmonary Edema With Heart Failure
Herlev Hospital
Herlev
Odense University Hospital
Odense
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions